BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6288701)

  • 1. The binding of fibrinogen to its platelet receptor.
    Marguerie GA; Ardaillou N; Cherel G; Plow EF
    J Biol Chem; 1982 Oct; 257(20):11872-5. PubMed ID: 6288701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of fibrinogen receptor-mediated platelet aggregation by heterologous anti-human platelet membrane antibody. Significance of an Mr = 66,000 protein derived from glycoprotein IIIa.
    Kornecki E; Tuszynski GP; Niewiarowski S
    J Biol Chem; 1983 Aug; 258(15):9349-56. PubMed ID: 6308003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen fragment D is a recognition site for release-related platelet aggregation.
    Agam G; Shohat O; Livne A
    Thromb Res; 1985 Mar; 37(6):629-38. PubMed ID: 3992532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex formation of platelet membrane glycoproteins IIb and IIIa with the fibrinogen D domain.
    Nachman RL; Leung LL; Kloczewiak M; Hawiger J
    J Biol Chem; 1984 Jul; 259(13):8584-8. PubMed ID: 6234315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of the fibrinogen receptor on human platelets by epinephrine and the combination of epinephrine and ADP.
    Plow EF; Marguerie GA
    J Biol Chem; 1980 Nov; 255(22):10971-7. PubMed ID: 6253495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of platelet-associated fibrinogen by polyclonal antibodies: correlation with platelet aggregation.
    Peerschke EI
    Blood; 1992 Apr; 79(8):2028-33. PubMed ID: 1562729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the gamma chain platelet binding site on fibrinogen fragment D.
    Kirschbaum NE; Mosesson MW; Amrani DL
    Blood; 1992 May; 79(10):2643-8. PubMed ID: 1586714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of thrombospondin in platelet aggregation.
    Leung LL
    J Clin Invest; 1984 Nov; 74(5):1764-72. PubMed ID: 6501568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets.
    Gartner TK; Bennett JS
    J Biol Chem; 1985 Oct; 260(22):11891-4. PubMed ID: 2995350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of intracellular fibrinogen on the surface of stimulated platelets.
    Courtois G; Ryckewaert JJ; Woods VL; Ginsberg MH; Plow EF; Marguerie GA
    Eur J Biochem; 1986 Aug; 159(1):61-7. PubMed ID: 3743572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet aggregation: its relation with ADP-induced fibrinogen binding to platelets and ADP-related membrane enzyme activities.
    Legrand C; Dubernard V; Caen J
    Eur J Biochem; 1984 Aug; 142(3):465-71. PubMed ID: 6088225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta 3 integrin derived peptide 217-230 inhibits fibrinogen binding and platelet aggregation: significance of RGD sequences and fibrinogen A alpha-chain.
    Lasz EC; McLane MA; Trybulec M; Kowalska MA; Khan S; Budzynski AZ; Niewiarowski S
    Biochem Biophys Res Commun; 1993 Jan; 190(1):118-24. PubMed ID: 8422238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity labeling of a human platelet membrane protein with 5'-p-fluorosulfonylbenzoyl adenosine. Concomitant inhibition of ADP-induced platelet aggregation and fibrinogen receptor exposure.
    Figures WR; Niewiarowski S; Morinelli TA; Colman RF; Colman RW
    J Biol Chem; 1981 Aug; 256(15):7789-95. PubMed ID: 6267026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased accessibility of platelet-bound fibrinogen to antibody and enzyme probes.
    Peerschke EI
    Blood; 1989 Aug; 74(2):682-9. PubMed ID: 2526667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of 125I-labelled fibrin(ogen) fragments to platelets and to immunoprecipitated glycoprotein IIb-IIIa complex.
    Thorsen LI; Brosstad F; Gogstad G; Sletten K; Solum NO
    Thromb Res; 1986 Jun; 42(5):645-59. PubMed ID: 2424122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody.
    Bennett JS; Hoxie JA; Leitman SF; Vilaire G; Cines DB
    Proc Natl Acad Sci U S A; 1983 May; 80(9):2417-21. PubMed ID: 6302680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fibrinogen-dependent pathway of platelet aggregation.
    Marguerie GA; Plow EF
    Ann N Y Acad Sci; 1983 Jun; 408():556-66. PubMed ID: 6307106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competitions between fibrinogen with its degradation products for interactions with the platelet-fibrinogen receptor.
    Thorsen LI; Brosstad F; Gogstad G; Sletten K; Solum NO
    Thromb Res; 1986 Dec; 44(5):611-23. PubMed ID: 3810563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody.
    Lombardo VT; Hodson E; Roberts JR; Kunicki TJ; Zimmerman TS; Ruggeri ZM
    J Clin Invest; 1985 Nov; 76(5):1950-8. PubMed ID: 2414325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain.
    Puri RN; Zhou FX; Bradford H; Hu CJ; Colman RF; Colman RW
    Arch Biochem Biophys; 1989 Jun; 271(2):346-58. PubMed ID: 2543293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.